Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration January 18, 2023 02:02 PM Eastern Standard Time ...

SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development of ...

Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism. Daphne Ruth Friedman , Tiffany Stewart , Eross ...

Caspase-1 leaves the inflammasome and goes off to activate several cytokines, including IL-1β (4), as well as a protein called gasdermin-D (not pictured), which causes cells to explode and ...

Eyedrops with a caspase-9 inhibitor prevent retinal injury from retinal vein occlusion. In the left image, RVO causes swelling in the retina and the retinal layers are less distinct. In the right ...

A total of 317 patients with CLL or SLL received pirtobrutinib, including 247 who had previously received a BTK inhibitor. Among these 247 patients, the median number of previous lines of therapy ...

The most frequently used factor Xa inhibitor was apixaban (62.5% of patients in the andexanet group and 59.2% in the usual-care group). The baseline median hematoma volume was 10.5 ml ...